A Drug Utilization Study in Patients Suffering From Gastro-Intestinal (G.I.) Cancer at a Tertiary Care Teaching Hospital
Authors/Creators
- 1. Resident Doctor, Department of Pharmacology, GCSMCH & RC, Ahmedabad, Gujarat
- 2. Senior Resident Doctor, Department of Pharmacology, GMERS Medical College, Gandhinagar, Gujarat
- 3. Assistant Professor, Department of Pharmacology, GCSMCH & RC, Ahmedabad, Gujarat
- 4. Ex- Professor & Head of the Department of Pharmacology, GCSMCH & RC, Ahmedabad, Gujarat
- 5. Professor & Head of the Department of Pharmacology, GMERS Medical College, Gandhinagar, Gujarat
Description
Objective: The objective of the study is to evaluate utilization patterns of drugs in patients suffering from Gastro-intestinal (G.I.) cancer at a tertiary care teaching hospital. Materials and Methods: This prospective, observational study was carried out at the Department of Pharmacology and Oncology, GCS Medical College, Hospital and Research Centre, Ahmedabad, to assess the drug utilization pattern in patients of cancer. The study was carried out over a period of 19 months from August 2019 to March 2021. A total of 43 patients were enrolled for the study. Patient’s demographic, clinical, and therapeutic data were collected from the files and in person ward visit and analyzed in Microsoft Excel version 2015. Results: Diagnosis of G.I carcinoma was highest in age group of >60 years (44.19 %). Colon (23.26%) was commonest organ affected followed by esophagus (16.28%) and stomach (11.63%) subsequently. Family history of cancer was seen in 25.6% patients, while 51.2% gave history of Tobacco consumption. Oxaliplatin and CAP: Capecitabine (OXA + CAP) was the most commonly used initial combination followed by CAR: Carboplatin and PAC: Paclitaxel (PAC + CAR).
Abstract (English)
Objective: The objective of the study is to evaluate utilization patterns of drugs in patients suffering from Gastro-intestinal (G.I.) cancer at a tertiary care teaching hospital. Materials and Methods: This prospective, observational study was carried out at the Department of Pharmacology and Oncology, GCS Medical College, Hospital and Research Centre, Ahmedabad, to assess the drug utilization pattern in patients of cancer. The study was carried out over a period of 19 months from August 2019 to March 2021. A total of 43 patients were enrolled for the study. Patient’s demographic, clinical, and therapeutic data were collected from the files and in person ward visit and analyzed in Microsoft Excel version 2015. Results: Diagnosis of G.I carcinoma was highest in age group of >60 years (44.19 %). Colon (23.26%) was commonest organ affected followed by esophagus (16.28%) and stomach (11.63%) subsequently. Family history of cancer was seen in 25.6% patients, while 51.2% gave history of Tobacco consumption. Oxaliplatin and CAP: Capecitabine (OXA + CAP) was the most commonly used initial combination followed by CAR: Carboplatin and PAC: Paclitaxel (PAC + CAR).
Files
IJPCR,Vol15,Issue12,Article100.pdf
Files
(412.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:da38b740367437dfe8c8e80bdac5388f
|
412.0 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-11-30
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue12,Article100.pdf
- Development Status
- Active
References
- 1. Introduction to drug utilization research, 2013 2. Pentareddy MR, Suresh AV, Shailendra D, Subbaratnam Y, Prasuna G, Naresh DT, Rajsekhar K. Prescription pattern of anticancer drugs in a tertiary care hospital. Journal of Evidence based Medicine and Healthcare. 2015; 2(20):3001-9. 3. Mathur P, Sathishkumar K, Chaturvedi M, Das P, Sudarshan KL, Santhappan S, Nallasamy V, John A, Narasimhan S, Roselind FS; ICMRNCDIR-NCRP Investigator Group. Cancer Statistics, 2020: Report from National Cancer Registry Programme, India. JCO Glob Oncol. 2020 Jul; 6:1063-1075. 4. Asmatanzeem Bepari, Nayana Sakre, Ishrat Rahman, Shaik Kalimulla Niazi, Asmabi M. Dervesh. The Assessment of Drug Utilization Study of Anticancer Drugs Using WHO Prescribing Indicators in a Government Tertiary Care Hospital of the Hyderabad - Karnataka Region of India. Macedonian Journal of Medical Sciences. 2019 Apr 15; 7(7):1203-1208. 5. Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, Bray F. Global Burden of 5 Major Types of Gastrointestinal Cancer. Gastroenterology. 2020 Jul; 159(1):335-349.e15. 6. Schlesinger-Raab A, Werner J, Friess H, Hölzel D, Engel J. Age and Outcome in Gastrointestinal Cancers: A Population-Based Evaluation of Oesophageal, Gastric and Colorectal Cancer. Visc Med. 2017 Aug; 33(4):245-253. 7. Field KM, Kosmider S, Jefford M, Jennens R, Green M, Gibbs P. Chemotherapy treatments for metastatic colorectal cancer: is evidencebased medicine in practice? J Oncol Pract. 2008 Nov; 4(6):271-6. 8. Laszlo J. Antiemetics and cancer chemotherapy. Baltimore, MD: Williams & Wilkins; 1983 9. Fernández-Ortega P, Caloto MT, Chirveches E, et al.Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients' quality of life. Support Care Cancer. [Epub ahead of print Mar 31 2012].